Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $4.81M | $0.75 | $32.67 | 4,278.95% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $17.39M | $0.34 | $10.00 | 2,858.58% | Strong Buy | 2 | N/A | N/A | -35,899.88% | -513.21% | |||
| IMA | IMAGENEBIO INC | $34.63M | $8.61 | $153.00 | 1,677.00% | Buy | 2 | N/A | N/A | -25.37% | -23.31% | |||
| ATYR | ATYR PHARMA INC | $77.12M | $0.79 | $13.50 | 1,615.37% | Buy | 4 | 596.43% | N/A | -39.65% | -29.83% | |||
| ACXP | ACURX PHARMACEUTICALS INC | $8.84M | $5.58 | $95.50 | 1,611.47% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| CANF | CAN-FITE BIOPHARMA LTD | $4.71M | $0.40 | $6.75 | 1,604.55% | Strong Buy | 2 | 719.66% | N/A | N/A | N/A | |||
| NRXP | NRX PHARMACEUTICALS INC | $49.07M | $2.49 | $40.33 | 1,519.80% | Strong Buy | 3 | N/A | N/A | -282.17% | 2,077.22% | |||
| MRSN | MERSANA THERAPEUTICS INC | $44.47M | $8.91 | $140.00 | 1,471.27% | Strong Buy | 2 | -29.73% | N/A | N/A | -29.19% | |||
| FGEN | FIBROGEN INC | $40.21M | $9.94 | $146.50 | 1,373.84% | Buy | 2 | N/A | N/A | N/A | -25.33% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $168.92M | $0.50 | $7.00 | 1,294.42% | Buy | 3 | 48.30% | N/A | 842.99% | 59.37% | |||
| PSTV | PLUS THERAPEUTICS INC | $78.33M | $0.57 | $7.75 | 1,259.65% | Strong Buy | 4 | 55.70% | N/A | -83.21% | -22.52% | |||
| TVRD | TVARDI THERAPEUTICS INC | $39.29M | $4.19 | $55.50 | 1,224.58% | Strong Buy | 6 | N/A | N/A | -118.52% | -89.20% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $29.40M | $2.02 | $26.67 | 1,220.15% | Buy | 3 | 307.92% | N/A | N/A | -57.00% | |||
| ACET | ADICET BIO INC | $99.00M | $0.65 | $8.50 | 1,215.79% | Strong Buy | 2 | N/A | N/A | -59.80% | -46.46% | |||
| GRI | GRI BIO INC | $4.65M | $1.85 | $22.50 | 1,116.22% | Buy | 2 | N/A | N/A | -26.77% | -15.67% | |||
| LSTA | LISATA THERAPEUTICS INC | $18.52M | $2.10 | $23.50 | 1,019.05% | Strong Buy | 2 | 60.27% | N/A | -50.75% | -40.52% | |||
| CING | CINGULATE INC | $19.86M | $3.67 | $39.50 | 976.29% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| JSPR | JASPER THERAPEUTICS INC | $47.57M | $1.70 | $18.13 | 966.18% | Buy | 8 | N/A | N/A | -761.65% | -153.35% | |||
| SKYE | SKYE BIOSCIENCE INC | $46.80M | $1.46 | $15.00 | 927.40% | Buy | 3 | N/A | N/A | -225.05% | -178.83% | |||
| MTVA | METAVIA INC | $18.57M | $0.77 | $7.50 | 877.84% | Strong Buy | 2 | N/A | N/A | -1,786.79% | -766.15% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $24.81M | $1.04 | $10.00 | 861.54% | Strong Buy | 2 | N/A | N/A | -120.06% | -101.23% | |||
| MYO | MYOMO INC | $32.67M | $0.85 | $7.83 | 821.53% | Buy | 3 | 12.85% | N/A | 50.43% | 21.64% | |||
| VNRX | VOLITIONRX LTD | $40.89M | $0.38 | $3.50 | 821.05% | Strong Buy | 3 | 262.15% | N/A | -322.53% | 1,178.82% | |||
| SLN | SILENCE THERAPEUTICS PLC | $317.09M | $6.72 | $61.67 | 817.66% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| IMUX | IMMUNIC INC | $74.74M | $0.78 | $7.00 | 797.44% | Strong Buy | 4 | N/A | N/A | -654.43% | 168.66% | |||
| PMN | PROMIS NEUROSCIENCES INC | $20.72M | $0.40 | $3.50 | 775.00% | Strong Buy | 2 | N/A | N/A | N/A | -398.95% | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $9.22M | $1.61 | $14.00 | 769.57% | Buy | 2 | N/A | N/A | -23.72% | -21.19% | |||
| MBRX | MOLECULIN BIOTECH INC | $14.51M | $0.48 | $4.00 | 735.07% | Buy | 2 | N/A | N/A | N/A | -603.73% | |||
| TIL | INSTIL BIO INC | $106.32M | $15.75 | $125.00 | 693.65% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| CTSO | CYTOSORBENTS CORP | $43.70M | $0.70 | $5.50 | 687.97% | Buy | 2 | 21.29% | N/A | N/A | N/A | |||
| PASG | PASSAGE BIO INC | $24.48M | $7.70 | $59.25 | 669.48% | Strong Buy | 4 | N/A | N/A | -3.65% | -1.53% | |||
| FEMY | FEMASYS INC | $25.63M | $0.94 | $7.00 | 643.89% | Strong Buy | 2 | 155.46% | N/A | -125.24% | -18.83% | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $9.23M | $4.81 | $35.67 | 641.52% | Buy | 3 | 37.00% | N/A | -109.83% | -56.51% | |||
| HUMA | HUMACYTE INC | $202.72M | $1.28 | $9.17 | 616.17% | Strong Buy | 6 | 379.66% | N/A | 14,989.86% | 437.62% | |||
| NAKA | KINDLY MD INC | $5.32M | $0.70 | $5.00 | 614.29% | Strong Buy | 2 | 470.58% | N/A | -1.73% | -1.57% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $106.95M | $0.83 | $5.88 | 609.54% | Buy | 2 | N/A | N/A | -74.22% | -66.37% | |||
| RNXT | RENOVORX INC | $39.21M | $1.07 | $7.50 | 600.93% | Buy | 2 | 283.58% | N/A | 94.84% | 73.97% | |||
| ZSPC | ZSPACE INC | $17.39M | $0.73 | $5.00 | 585.87% | Strong Buy | 2 | -12.15% | N/A | N/A | -120.27% | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $12.06M | $9.57 | $65.00 | 579.56% | Buy | 2 | N/A | N/A | -67.83% | -58.29% | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $278.67M | $1.24 | $8.00 | 545.16% | Strong Buy | 7 | N/A | N/A | -51.85% | -37.18% | |||
| AVXL | ANAVEX LIFE SCIENCES CORP | $588.37M | $6.85 | $44.00 | 542.34% | Strong Buy | 2 | N/A | N/A | 1,057.61% | 939.14% | |||
| ANVS | ANNOVIS BIO INC | $41.12M | $2.11 | $13.50 | 539.81% | Strong Buy | 2 | N/A | N/A | -166.98% | -142.67% | |||
| IFRX | INFLARX NV | $111.78M | $1.65 | $10.33 | 526.24% | Strong Buy | 3 | 215.41% | N/A | -75.48% | -52.55% | |||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $21.76M | $1.90 | $11.50 | 505.26% | Strong Buy | 2 | 133.47% | N/A | -1.87% | -1.34% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.